CRISM' Therapeutics Corp recorded one insider purchase on June 3, 2024, when Non-Executive Director Gerald Beaney acquired 25,000 shares for a total value of 2,316.25 dollars. This represents the sole activity observed within the provided records, occurring over three months ago.